tiprankstipranks
Acerus Pharmaceuticals (ASPCQ)
OTHER OTC:ASPCQ
Holding ASPCQ?
Track your performance easily

Acerus Pharmaceuticals (ASPCQ) Technical Analysis

0 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
1Neutral
13Bearish
Technical Analysis Consensus
Buy
4Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Acerus Pharmaceuticals’s (ASPCQ) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Acerus Pharmaceuticals is a Sell.
Acerus Pharmaceuticals’s (ASPCQ) 20-Day exponential moving average is 0.22, while Acerus Pharmaceuticals’s (ASPCQ) share price is $0.22, making it a Sell.
Acerus Pharmaceuticals’s (ASPCQ) 50-Day exponential moving average is 0.22, while Acerus Pharmaceuticals’s (ASPCQ) share price is $0.22, making it a Sell.

Acerus Pharmaceuticals (ASPCQ) Pivot Points

Nov 22, 2024, 01:40 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.22
0.22
0.22
0.22
0.22
0.22
0.22
Fibonacci
0.22
0.22
0.22
0.22
0.22
0.22
0.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Acerus Pharmaceuticals (ASPCQ) Moving Averages

Nov 22, 2024, 01:40 PM
Period
Simple
Exponential
MA5
0.22Sell
0.22Sell
MA10
0.22Sell
0.22Sell
MA20
0.22Buy
0.22Sell
MA50
0.22Buy
0.22Sell
MA100
0.22Sell
0.29Sell
MA200
0.48Sell
0.64Sell
Acerus Pharmaceuticals’s (ASPCQ) 10-Day exponential moving average is 0.22, while Acerus Pharmaceuticals’s (ASPCQ) share price is $0.22, making it a Sell.
Acerus Pharmaceuticals’s (ASPCQ) 100-Day exponential moving average is 0.29, while Acerus Pharmaceuticals’s (ASPCQ) share price is $0.22, making it a Sell.
Acerus Pharmaceuticals’s (ASPCQ) stock price is $0.22 and Acerus Pharmaceuticals’s (ASPCQ) 50-day simple moving average is 0.22, creating a Buy signal.
Acerus Pharmaceuticals’s (ASPCQ) stock price is $0.22 and Acerus Pharmaceuticals’s (ASPCQ) 100-day simple moving average is 0.22, creating a Sell signal.
Acerus Pharmaceuticals’s (ASPCQ) stock price is $0.22 and Acerus Pharmaceuticals’s (ASPCQ) 200-day simple moving average is 0.48, creating a Sell signal.

Acerus Pharmaceuticals (ASPCQ) Technical Indicators

Nov 22, 2024, 01:40 PM
Name
Value
Implied Action
RSI (14)
12.97
Buy
STOCH (9,6)
<0.01
Buy
STOCHRSI (14)
>-0.01
Buy
MACD (12,26)
>-0.01
Sell
ADX (14)
49.72
Neutral
CCI (14)
0.00
-
ATR (14)
<0.01
-
Ultimate Oscillator
100.00
Buy
ROC
0.00
-
Bull/Bear Power (13)
>-0.01
Sell
Acerus Pharmaceuticals’s (ASPCQ) Relative Strength Index (RSI) is 12.97, creating a Buy signal.
Acerus Pharmaceuticals’s (ASPCQ) Trend Strength Indicator (ADX) is 49.72, creating a Neutral signal.

FAQ

Is ASPCQ a Buy, Hold, or Sell?
Based on ASPCQ’s technical indicators, ASPCQ is a Sell.
    What is ASPCQ’s RSI (14)?
    ASPCQ’s RSI (14) is 12.97, which suggests ASPCQ is a Buy.
      What is ASPCQ’s MACD?
      ASPCQ’s MACD is >-0.01, which suggests ASPCQ is a Sell.
        What is ASPCQ’s 5-day moving average?
        ASPCQ’s 5-day moving average is 0.22, which suggests ASPCQ is a Sell.
          What is ASPCQ’s 20-day moving average?
          ASPCQ 20-day moving average is 0.22, which suggests ASPCQ is a Buy.
            What is ASPCQ’s 50-day moving average?
            ASPCQ’s 50-day moving average is 0.22, which suggests ASPCQ is a Buy.
              What is ASPCQ’s 200-day moving average?
              ASPCQ’s 200-day moving average is 0.48, which suggests ASPCQ is a Sell.
                What is ASPCQ’s Williams % R (14)?
                Currently, no data Available
                What is ASPCQ’s CCI (14)?
                Currently, no data Available
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis